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Anesthesiology is one of the most important creations of the modern science, 
basically based on the anesthetic drugs; however, there are a few concerns 
regarding the effects of the anesthetic drugs. Would there be any progress in 
the current trend of anesthesiology, both clinically and basically. There would 
be a possibility to use the physiologic mechanisms of sleep to be incorporated 
into clinical practice instead of pharmacologic agents in order to decrease 
their unwanted effects. 
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Anesthesiology is a relatively new convention 
of medicine. Many surgeries are nowadays performed 
just because we can anesthetize patients; otherwise, 
there was no progress in the many fields of surgery. 
In the United States, nearly 60,000 patients are 
anesthetized each day, mainly for surgical operation. 
The first time that anesthesia was "created", 
one of the greatest fears of mankind was overcome 
(1): since the first patient was anesthetized in October 
16, 1846 by Dr William T. G. Morton at 
Massachusetts General Hospital, Boston, the science 
and practice of anesthesiology has made many great 
developments, increasing its efficacy and safety and 
at the same time, decreasing the anesthesia-related 
morbidity and mortality (2, 3). 
In the current era of modern anesthesiology, 
the practice and science of anesthesia is composed of 
4 basic elements; each being one of its permanent 
counterparts; without each of them, anesthesia is not 
complete. These 4 basic elements are (4, 5): 
1) hypnosis (an iatrogenic pharmacologic-
based coma) 
2) amnesia (forgetting the unpleasant events 
during operation) 
3) analgesia (painlessness) 
4) akinesia (lack of movements in response to 
noxious stimuli, including the surgical 
incisions and manipulations). 
Very interesting issue is that all of these basic 
elements of anesthesia are created after interaction of 
anesthetic drugs with different parts of the nervous 
system (including central, peripheral, and autonomic 
nervous systems). However, CNS remains the 
primary site of action for "anesthesia". In other words, 
anesthesia is an iatrogenic, reversible, pharmacologic-
based coma; affecting CNS neuronal circuits at many 
levels including the molecular level; for example, the 
mechanism of anesthesia in some volatile agents (i.e. 
Isoflurane and Sevoflurane) is through inhibition of 
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orexinergic neurons; also, ketamine acts through 
“pyramidal cells and also, seven different types of 
CA1 interneurons” (6-13) or amnesia is induced 
primarily through effects of anesthetics on 
hippocampus neurons (14-16). Also, the majority of 
CNS anesthetics act through N-methyl-D-aspartate 
(NMDA) receptor or gamma-amino butyric acid 
(GABA) receptor subunits (17-30). 
Globally, some believe that anesthesia 
induction is due to “drug-induced global modulation 
of neuronal function”; meanwhile, termination of 
anesthesia is spontaneous and passive, occurring after 
termination of pharmacologic effects of anesthetics 
from “their sites in the central nervous system”; 
though this mechanism might be somewhat 
oversimplification and the neural inertia could have a 
role (31-36). 
But are we doing anesthesia in a right way? 
Are the modern anesthetic drugs as safe and 
physiology-compatible as we want? To answer this 
questions, one could consider the many animal and 
human studies proving the very safe anesthetic agents 
and the very diminutive incidence of unwanted effects 
of anesthetic drugs. Despite the many available proofs 
for modern anesthesia safety, there are some 
considerations regarding the effects of anesthetics on 
organ functions described in the following 
paragraphs. 
If we want to discuss more specifically, 
anesthesia is not so much physiologic. It is 
demonstrated in cerebral cortex and hippocampus 
neurons of rats that neuronal spikes from these sites 
are “very stable across physiologic states i.e. waking, 
slow-wave sleep and rapid-eye-movement sleep”; 
however, these neuronal spikes and avalanches 
“would collapse during anesthesia”. Also, waiting 
time distributions obey a single scaling function 
during all natural behavioral states, but not during 
anesthesia (34, 36-38). 
From another viewpoint, anesthesia is an 
iatrogenic pharmacologic based coma; of course with 
a reversible nature. In fact, electroencephalographic 
studies performed in patients undergoing general 
anesthesia has demonstrated an EEG pattern similar 
to patients with coma; in other words, the EEG waves 
in "comatose patients" and "patients undergoing 
general anesthesia" both demonstrate high amplitude, 
low-frequency waves (4, 39, 40). 
Now let's discuss the issue from a different 
viewpoint; i.e. the neurophysiologic point of view. 
During normal sleep, the arousal status is depressed 
and we would go unconscious. During the rapid eye 
movement (REM) phase of sleep, EEG waves have an 
active high-frequency, low-amplitude pattern; while 
in the non- rapid eye movement (Non-REM) phase of 
sleep the EEG waves are high amplitude, low 
frequency (33, 39-44). In contrast to this dual stage 
pattern of EEG in sleep, the EEG pattern in "general 
anesthesia" or "coma" has high amplitude, low-
frequency waves. Although coma and general 
anesthesia have some similarities with the Non-REM 
phase of sleep, "coma and general anesthesia" are not 
the same as Non-REM (4, 32, 41, 45, 46). As we see, 
EEG assessments also suggest us that possibly; the 
current anesthetic pharmacologic agents are not as 
physiologic as we need. 
Concerning the clinical point of view may be 
all above comments are not as worrying as the 
following lines of this paragraph; which addresses a 
sample of the many studies published mainly in the 
last decade. There are an increasing number of 
evidence demonstrating the unwanted effects of 
anesthetic agents on the synaptogenesis processes in 
the animal neonates receiving modern anesthetic 
agents; these animal and lab studies have 
demonstrated the clues to apoptotic effects of 
anesthetics; some even well demonstrating these 
effects on animal CNS; though human CNS studies 
are not so much available due to technical problems 
(12, 46-74); also, there are a number of studies raising 
the questions regarding the effects of some of the 
current anesthetic agents on the behavioral and 
learning aspects of the human neonates, though none 
of them still have not presented definite proof for this 
effect (75). 
There are some new windows which could help 
us use the sleep mechanism as a “physiologic 
mechanism” instead of the current “pharmacologic 
mechanism” for anesthesia. In one direction, there is a 
concordance between interventions which disturb 
sleep and/or cause some types of somatic pain; in 
other words, these interventions have the “same 
direction effects” for pain and sleep; i.e. there is a 
concordance between them (76-79); so, possibly we 
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could use the physiologic mechanisms maintaining 
normal sleep for suppressing those surgical stimuli 
which create pain. On the other hand, we could use 
some newer molecules like urethane which could 
induce anesthesia with mechanisms different from 
current anesthetics; it means that urethane induces 
anesthesia with a mechanism “closely mimicking 
natural sleep” (8, 80-83). 
Conclusion 
The above paragraphs are brief concerns 
regarding the importance of a new look at our current 
approach for a very common medical practice. In 
other words, in the current era of clinical and basic 
studies, the effects of anesthetic agents in creating the 
"pharmacological coma" is a very important concern 
with high priority, in medicine, in pharmaceutical 
studies and more importantly, in neuroscience. We 
anticipate a very important turning point, which 
would add another improvement to the safety of 
anesthesia and add another revolution to the previous 
"jump up's" of this field of medicine, as a number of 
relatively safe anesthetic agents have emerged and 
shown to be neuroprotective (5, 84-90); however, this 
time, the turning point would be at the cellular and 
subcellular levels. 
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